CN Bio appoints Joseph Parisi as US Director of Sales to support accelerated growth in key OOC market
Cambridge, UK, 30 January 2024: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single- and multi-organ microphysiological systems (MPS), announces the appointment of Joseph Parisi as US Director of Sales.
SciTribe logo design
Angie Moyes writes...I worked with Dr Priya Kalia on her ‘SciTribe’ logo. Priya knew that she wanted a typewriter font and came to me to further develop the idea. Priya wanted her branding to feel more ‘together’ as her business, that offers strategic communications consulting focused on science & technology, was growing.
Enterprise Therapeutics Closes £26 million ($33.1 million) Series B Follow-on Financing
Round led by new investor Panakes, with participation from all existing investors Funding will support Phase 2a clinical proof of concept trial in cystic fibrosis for a novel first in class ENaC blocker (ETD001) and pipeline expansionQueensgate awarded funding for fourth research project with NPL
Queensgate, a brand of Prior Scientific, has won funding from Innovate UK, the UK’s innovation agency, for a fourth nanopositioning research project as part of Analysis for Innovators (A4I) program (Round 11).
Asimov launches LV Edge Packaging System to optimize lentivirus production
Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the launch of their LV Edge Packaging System, which improves the cost efficiency and reduces the supply chain risk of lentiviral production.
TV thank you was One Big surprise for James
A Queen Elizabeth Hospital porter, who wanted to thank an Addenbrooke’s consultant on national television for saving his life after a stroke, suddenly found himself at the centre of an emotional surprise.
Leading UK and South African genomics labs unite to take disease surveillance beyond Covid
Genomic surveillance laboratories in the UK and South Africa, renowned for their work identifying new variants during the COVID-19 pandemic, have joined forces to identify emerging threats from infectious diseases.
Don't miss your chance to enter the Cambridge Independent Science and Technology Awards 2024
The deadline is January 31.
EUROAPI enhances its CDMO capabilities through a pivotal collaboration with SpiroChem, a leading Contract Research Organization (CRO)
This collaboration will ensure the continuity of API development, from route scouting to process industrialization and GMP manufacturing EUROAPI and SpiroChem to provide clients with consolidated CRO-CDMO customized solutions to accelerate API chemical development and shorten timelines, especially for early-stage projects and the biotech segment. This agreement will strengthen EUROAPI’s Contract…
Transforming Healthcare Podcast: CES and the opportunities for the medical and health technology sector
In this episode, host, Jay Evans is joined by Dr Bipin Patel and a special guest for this podcast, Karla Pequenino, a journalist at Publico in Portugal.
Cellular Origins, a TTP Company, appoints Peter Crossley as Chief Operating Officer
Product and technology innovator will build team to further develop and deliver Cellular Origins’ products for cell and gene therapy manufacture at scaleCAMBRIDGE, UK - Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and e
Impact of the EU's general pharmaceutical legislation on Europe's innovation ecosystem and biotechnology companies
EuropaBio asked Charles River Associates to research the potential impact of the proposed changes included within the EU’s General Pharmaceutical Legislation (GPL) to Europe’s innovation ecosystem, with a particular focus on its impact on the growth of emerging and small biotechnology companies.
BenevolentAI appoints Dr. Joerg Moeller as Chief Executive Officer
An accomplished R&D leader and champion of the application of AI to drug discovery.
HCA Healthcare UK, the leading private hospital group adopts Versius in UK first
The Wellington Hospital as one of the largest private hospitals in the UK has now also become the first hospital in the UK private sector to offer robotic assisted surgery with Versius.
NIHR BioResource Scientific Conference to return in June 2024
NIHR BioResource are excited to announce the NIHR BioResource Scientific Conference will return later this year, hosted online on Wednesday 19 June 2024 from 9.30am to 12.30pm. Leading academics and industry researchers will present their recent work and the unique role of the NIHR BioResource in delivering translational research across a range of disease areas.
Elevating balance and vestibular care at angli-EAR Hearing with the arrival of James Saladine
angli-EAR Hearing proudly welcomes James Saladine, a highly experienced Balance and Vestibular Physiotherapist, to its expert team. With a background in Vestibular Rehabilitation Physiotherapy, James enhances the clinic's offerings, focusing on managing debilitating dizziness symptoms for clients and reducing the risk of falls through unsteadiness.
CN Bio and Altis Biosystems partner to develop next-generation human Gut/Liver in vitro model for advanced ADME studies
Cambridge, UK, and Durham, North Carolina, US - CN Bio and Altis Biosystems, Inc., leading developers of in vitro human organ models that optimize the accuracy and efficiency of drug development, announces a strategic partnership.
PlaqueTec and the Babraham Institute collaborate on phenotypic screen of coronary artery blood
Collaboration to develop a bespoke cell phenotyping assay for human blood Project aims to investigate cell types present in coronary artery samples from patients with CAD participating in PlaqueTec’s BIOPATTERN trial Assay will be available as a service in the BabrahamCalluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases
· Clinical stage company formed from the merger of Oxitope Pharma and Arxx Therapeutics · Calluna Pharma has a pipeline of selective antibodies targeting immunological diseases
Targeting annexin-A1 can halt cancer cell growth
New study shows effectiveness of first drug to focus on cancer-causing protein.
New NHS blood group genotyping test developed with BioResource launches today
From today, almost 18,000 people in England with sickle cell disorder and thalassaemia can have a world-first genetic test to better match future blood transfusions, reducing the risk of side effects.
Arecor granted key european patent extending protection for insulin products, AT278 and AT247
Cambridge, UK - Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, is pleased to announce that the European Patent Office has granted a patent (EP3618840) protecting novel formulations of the Group’s proprietary insulin products, AT278 and AT247.
Seeking managers for research interviews on workplace wellbeing decisions
The UEA workplace wellbeing team calls for UK managers of any level, any sector, to take part in new research about decision-making on workplace wellbeing activities.